These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 26080803)
21. Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior. Dai YJ; Qiu YB; Jiang R; Xu M; Liao LY; Chen GG; Liu ZM Cell Oncol (Dordr); 2018 Jun; 41(3):269-282. PubMed ID: 29368272 [TBL] [Abstract][Full Text] [Related]
22. Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro. Gu W; Dong N; Wang P; Shi C; Yang J; Wang J Cell Biol Toxicol; 2017 Apr; 33(2):183-195. PubMed ID: 27837347 [TBL] [Abstract][Full Text] [Related]
23. Expression of ERα36 in gastric cancer samples and their matched normal tissues. Wang J; Li J; Fang R; Xie S; Wang L; Xu C Oncol Lett; 2012 Jan; 3(1):172-175. PubMed ID: 22740875 [TBL] [Abstract][Full Text] [Related]
24. ERα36, a new variant of the ERα is expressed in triple negative breast carcinomas and has a specific transcriptomic signature in breast cancer cell lines. Pelekanou V; Notas G; Kampa M; Tsentelierou E; Radojicic J; Leclercq G; Castanas E; Stathopoulos EN Steroids; 2012 Aug; 77(10):928-34. PubMed ID: 22198466 [TBL] [Abstract][Full Text] [Related]
25. Gene expression signature of estrogen receptor alpha status in breast cancer. Abba MC; Hu Y; Sun H; Drake JA; Gaddis S; Baggerly K; Sahin A; Aldaz CM BMC Genomics; 2005 Mar; 6():37. PubMed ID: 15762987 [TBL] [Abstract][Full Text] [Related]
26. Expression Significance of Estrogen Receptor ER-α36 in Breast Cancer Treated by Chemotherapy: A Meta-Analysis. He E; Xia X; Quan H; Leng P Mol Biotechnol; 2024 May; 66(5):991-999. PubMed ID: 38270756 [TBL] [Abstract][Full Text] [Related]
27. β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases. Bleckmann A; Conradi LC; Menck K; Schmick NA; Schubert A; Rietkötter E; Arackal J; Middel P; Schambony A; Liersch T; Homayounfar K; Beißbarth T; Klemm F; Binder C; Pukrop T Clin Exp Metastasis; 2016 Apr; 33(4):309-23. PubMed ID: 26862065 [TBL] [Abstract][Full Text] [Related]
28. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen. Morrissey JJ; Raney S Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849 [TBL] [Abstract][Full Text] [Related]
29. NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways. Ramos J; Das J; Felty Q; Yoo C; Poppiti R; Murrell D; Foster PJ; Roy D Breast Cancer Res Treat; 2018 Nov; 172(2):469-485. PubMed ID: 30128822 [TBL] [Abstract][Full Text] [Related]
30. The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1). Najim O; Huizing M; Papadimitriou K; Trinh XB; Pauwels P; Goethals S; Zwaenepoel K; Peterson K; Weyler J; Altintas S; van Dam P; Tjalma W Cancer Treat Res Commun; 2019; 19():100123. PubMed ID: 30826563 [TBL] [Abstract][Full Text] [Related]
31. 17β-Estradiol inhibits testosterone-induced cell proliferation in HepG2 by modulating the relative ratios of 3 estrogen receptor isoforms to the androgen receptor. Xu Z; Liu J; Jianxin C; Yongliang Z; Pan X J Cell Biochem; 2018 Nov; 119(10):8659-8671. PubMed ID: 30058741 [TBL] [Abstract][Full Text] [Related]
32. The analysis of estrogen receptor-α positive breast cancer stem-like cells unveils a high expression of the serpin proteinase inhibitor PI-9: Possible regulatory mechanisms. Lauricella M; Carlisi D; Giuliano M; Calvaruso G; Cernigliaro C; Vento R; D'Anneo A Int J Oncol; 2016 Jul; 49(1):352-60. PubMed ID: 27121069 [TBL] [Abstract][Full Text] [Related]
34. Structural insights into tumor-specific chaperoning activity of gamma synuclein in protecting estrogen receptor alpha 36 and its role in tamoxifen resistance in breast cancer. Panneerselvam M; Muthu K; Ramadas K Mol Biosyst; 2015 Nov; 11(11):2998-3010. PubMed ID: 26299756 [TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor-α variant, ER-α36, is involved in tamoxifen resistance and estrogen hypersensitivity. Zhang X; Wang ZY Endocrinology; 2013 Jun; 154(6):1990-8. PubMed ID: 23546601 [TBL] [Abstract][Full Text] [Related]
36. Oligonucleotide microarray analysis of estrogen receptor alpha-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen. Tozlu-Kara S; Roux V; Andrieu C; Vendrell J; Vacher S; Lazar V; Spyratos F; Tubiana-Hulin M; Cohen P; Dessen P; Lidereau R; Bièche I J Mol Endocrinol; 2007 Oct; 39(4):305-18. PubMed ID: 17909269 [TBL] [Abstract][Full Text] [Related]
37. Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells. Lin CY; Ström A; Vega VB; Kong SL; Yeo AL; Thomsen JS; Chan WC; Doray B; Bangarusamy DK; Ramasamy A; Vergara LA; Tang S; Chong A; Bajic VB; Miller LD; Gustafsson JA; Liu ET Genome Biol; 2004; 5(9):R66. PubMed ID: 15345050 [TBL] [Abstract][Full Text] [Related]
38. Estrogen receptor-alpha 36 mediates the anti-apoptotic effect of estradiol in triple negative breast cancer cells via a membrane-associated mechanism. Chaudhri RA; Hadadi A; Lobachev KS; Schwartz Z; Boyan BD Biochim Biophys Acta; 2014 Nov; 1843(11):2796-806. PubMed ID: 25108195 [TBL] [Abstract][Full Text] [Related]
39. Role of ERα36 in membrane-associated signaling by estrogen. Chaudhri RA; Schwartz N; Elbaradie K; Schwartz Z; Boyan BD Steroids; 2014 Mar; 81():74-80. PubMed ID: 24252378 [TBL] [Abstract][Full Text] [Related]
40. Integrative analysis of histopathological images and chromatin accessibility data for estrogen receptor-positive breast cancer. Xu S; Lu Z; Shao W; Yu CY; Reiter JL; Feng Q; Feng W; Huang K; Liu Y BMC Med Genomics; 2020 Dec; 13(Suppl 11):195. PubMed ID: 33371906 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]